Cognitive and behavioral associated changes in manifest Huntington disease: A retrospective cross‐sectional study

Cognitive and behavioral associated changes in manifest Huntington disease: A retrospective cross‐sectional study

Abstract Introduction Behavioral and cognitive changes can be observed across all Huntington disease (HD) stages. Our multicenter and retrospective study investigated the association between cognitive and behavioral scale scores in manifest HD, at three different yearly timepoints. Methods We analyz...

Full description

Bibliographic Details
Main Authors:	Simone Migliore, Giulia D’Aurizio, Sabrina Maffi, Consuelo Ceccarelli, Giovanni Ristori, Silvia Romano, Anna Castaldo, Caterina Mariotti, Giuseppe Curcio, Ferdinando Squitieri
Format:	Article
Language:	English
Published:	Wiley 2021-07-01
Series:	Brain and Behavior
Subjects:	behavioral symptoms cognitive deficit dysexecutive syndrome HD progression Huntington disease
Online Access:	https://doi.org/10.1002/brb3.2151

Similar Items

Genetic Counseling in Huntington's Disease: Potential New Challenges on Horizon?
by: Simone Migliore, et al.
Published: (2019-04-01)

Cognitive and behavioural dysfunctions in a patient with progressive supranuclear palsy (PSP)
by: Katarzyna Olszewska, et al.
Published: (2019-01-01)

Emotion recognition and inhibitory control in manifest and pre-manifest Huntington's disease: evidence from a new Stroop task
by: Thomas Hunefeldt, et al.
Published: (2020-01-01)

Safer Attitude to Risky Decision-Making in Premanifest Huntington’s Disease Subjects
by: Giulia D’Aurizio, et al.
Published: (2019-04-01)

The Clinical Picture of Psychosis in Manifest Huntington's Disease: A Comprehensive Analysis of the Enroll-HD Database
by: Natalia P. Rocha, et al.
Published: (2018-11-01)

Optimization of trans-Splicing for Huntington's Disease RNA Therapy
by: Hansjörg Rindt, et al.
Published: (2017-10-01)

Juvenile Huntington disease in Argentina
by: Emilia Mabel Gatto, et al.
Published: (2015-01-01)

Effects of donepezil on behavioural manifestations of thalamic infarction: a single case observation
by: Rodrigo eRiveros, et al.
Published: (2011-03-01)

Mental disorders in Huntington’s disease
by: S. A. Klyushnikov, et al.
Published: (2014-01-01)

The Relationship Between Age-of-Onset and the Behavioral Phenotypic Manifestations in Huntington's Disease
by: Ranganathan, Megha
Published: (2018)

Chorea–Acanthocytosis and the Huntington Disease Allele in an Irish Family
by: Olwen C. Murphy, et al.
Published: (2018-10-01)

Neuroanatomical basis of behavioral disturbances in patients with prefrontal lesions
by: ANDREA SLACHEVSKY, et al.
Published: (2006-01-01)

Juvenile Huntington’s Disease Skin Fibroblasts Respond with Elevated Parkin Level and Increased Proteasome Activity as a Potential Mechanism to Counterbalance the Pathological Consequences of Mutant Huntingtin Protein
by: Azzam Aladdin, et al.
Published: (2019-10-01)

Longitudinal Evaluation of the Effect of Tricyclic Antidepressants and Neuroleptics on the Course of Huntington’s Disease—Data from a Real World Cohort
by: Jannis Achenbach, et al.
Published: (2021-03-01)

Juvenile Huntington’s disease masquerading as progressive myoclonus epilepsy
by: Bina Thakor, et al.
Published: (2021-01-01)

Perceptions about Research Participation among Individuals at Risk and Individuals with Premanifest Huntington’s Disease: A Survey Conducted by the European Huntington Association
by: Filipa Júlio, et al.
Published: (2021-08-01)

Utility of Huntington's Disease Assessments by Disease Stage: Floor/Ceiling Effects
by: Daisy Abreu, et al.
Published: (2021-07-01)

The dynamics of early-state transcriptional changes and aggregate formation in a Huntington’s disease cell model
by: Martijn van Hagen, et al.
Published: (2017-05-01)

Differential Diagnosis of Chorea—HIV Infection Delays Diagnosis of Huntington’s Disease by Years
by: Jannis Achenbach, et al.
Published: (2021-05-01)

Modified impact of emotion on temporal discrimination in a transgenic rat model of Huntington disease
by: Alexis eFaure, et al.
Published: (2013-09-01)

Low eGFR is associated with dysexecutive and amnestic mild cognitive impairment
by: Andrea R. Zammit, et al.
Published: (2015-06-01)

8OHdG as a marker for Huntington disease progression
by: Jeffrey D. Long, et al.
Published: (2012-06-01)

The epidemiology and clinical manifestations of dysexecutive syndrome in Parkinson’s disease
by: Roberto eCeravolo, et al.
Published: (2012-11-01)

Cross-Sectional Gender Comparison of Gray Matter Concentration in Prodromal Huntington’s Disease
by: Destiny Ogbu, et al.
Published: (2020-06-01)

A Touchscreen Motivation Assessment Evaluated in Huntington's Disease Patients and R6/1 Model Mice
by: Christopher J. Heath, et al.
Published: (2019-08-01)

Major Contribution of Somatostatin-Expressing Interneurons and Cannabinoid Receptors to Increased GABA Synaptic Activity in the Striatum of Huntington’s Disease Mice
by: Sandra M. Holley, et al.
Published: (2019-05-01)

Propensity for somatic expansion increases over the course of life in Huntington disease
by: Radhia Kacher, et al.
Published: (2021-05-01)

The effects of Rhes, a striatal specific protein, on the expression of behavioral and neuropathological symptoms in a transgenic mouse model of Huntington's disease
by: Baiamonte, Brandon A.
Published: (2012)

A transgenic minipig model of Huntington's disease shows early signs of behavioral and molecular pathologies
by: Georgina Askeland, et al.
Published: (2018-10-01)

Characterization of dental pulp stem/stromal cells of Huntington monkey tooth germs
by: Yang Jinjing, et al.
Published: (2011-09-01)

Known Drugs Identified by Structure-Based Virtual Screening Are Able to Bind Sigma-1 Receptor and Increase Growth of Huntington Disease Patient-Derived Cells
by: Theo Battista, et al.
Published: (2021-01-01)

Non-choreic movement disorders as initial manifestations of Huntington's disease Distúrbios do movimento não-coreicos como manifestação inicial da doença de Huntington
by: Nilson Becker, et al.
Published: (2007-06-01)

Plastic and behavioral abnormalities in experimental Huntington's disease: A crucial role for cholinergic interneurons
by: Barbara Picconi, et al.
Published: (2006-04-01)

Mitochondrial Respiration Changes in R6/2 Huntington’s Disease Model Mice during Aging in a Brain Region Specific Manner
by: Johannes Burtscher, et al.
Published: (2020-07-01)

The regulatory roles of microRNAs toward pathogenesis and treatments in Huntington's disease
by: Chih-Wei Tung, et al.
Published: (2021-08-01)

Impaired self-awareness after traumatic brain injury: Inter-rater reliability and factor structure of the Dysexecutive Questionnaire (DEX) in patients, significant others and clinicians.
by: Brian eMcGuire, et al.
Published: (2014-10-01)

Fronto-Subcortical Circuits for Cognition and Motivation: Dissociated Recovery in a Case of Loss of Psychic Self-Activation
by: Rodrigo Riveros, et al.
Published: (2019-01-01)

Alteraciones neuropsicológicas, extrapiramidales y neuroimagenológicas en la demencia frontotemporal
by: Dayamí Cantero Castro, et al.

DOES COGNITIVE IMPAIRMENT AFFECT REHABILITATION OUTCOME IN PARKINSON’S DISEASE?
by: Davide Ferrazzoli, et al.
Published: (2016-08-01)

Eye Movement Technique to Improve Executive Function in Patients With Stroke: A Randomized Controlled Trial
by: Wen He, et al.
Published: (2021-03-01)